Less Ads, More Data, More Tools Register for FREE

Pin to quick picksProvexis Regulatory News (PXS)

Share Price Information for Provexis (PXS)

Share Price is delayed by 15 minutes
Get Live Data
1.01    0.07 (7.45%)
Bid:
0.94
Ask:
1.08
Spread: 0.14 (14.894%)
Market Cap: £22.05m
PXS Live PriceLast checked at - London Stock Exchange

Intraday Provexis Share Chart

Trading Update

18 Feb 2005 07:02

Nutrinnovator Holdings PLC18 February 2005 For Immediate Release 18 February 2005 NUTRINNOVATOR HOLDINGS PLC ("Nutrinnovator" or "the Group") Trading Update The Board is updating shareholders on recent trading for the Altu food bar,which continues to be substantially behind expectations for the currentfinancial year. This situation has been further exacerbated by the recent eventsthat resulted in Nutrinnovator's sales agent, Food Brokers Limited, being placedinto administration. The Board is currently assessing contingency plans for thesales operation and expects to implement an alternative plan shortly. The Altufood bar continues to receive support from trade customers and consumers, andextended distribution in a current key multiple grocer account will be in placeduring March. Further progress in wholesale and convenience channels is expectedin April. Continued focus on financial controls will result in end of year cash balancesbeing slightly behind expectations, in view of these trading and operationaldifficulties. Nutrinnovator has continued to make progress in the area of establishingrelationships to develop novel functional foods. The Group has recently agreedin principle a joint venture with a substantial New Zealand research instituteto commercialise a heart health and cognitive development ingredient for which apatent is in the process of being filed, and which would also give Nutrinnovatorpreferential access to the development pipeline from the institute. In addition,a further agreement in principle has been reached with a UK-based researchinstitute to develop a functional food technology which is expected to result inclinically-proven and patented cancer prevention properties. The Nutrinnovator pipeline contains medium and long-term projects which, it isplanned, will result in the development of novel functional food products withintellectual property positions in the areas of heart health and cancerprevention. The Group continues to work alongside Provexis Limited in thedevelopment of its Cardioflow(R) heart-healthy drink with the expectation ofachieving a late summer 2005 launch of the product. In addition, despite theslower than planned sales of the Altu food bar brand, it is felt that as well asproviding a near-term revenue stream, this brand has the potential to provide afuture functional food platform. For further information please contact: Nutrinnovator Holdings plcStephen Moon, Managing Director 07967 564301 Buchanan Communications 020 7466 5000Tim Thompson / Tom Carroll Notes to editors: Nutrinnovator's strategy is to develop and market food and drink productsdesigned to be of overall superior nutritional quality to competing products inspecific product categories, whilst retaining the taste and palatability toappeal to the consumer. Health issues related to diet are significant in worldconsumer markets. Poor diet can lead to obesity which, in turn, can cause suchhealth issues as diabetes, heart disease, and high cholesterol. The founders ofNutrinnovator came together to form the business with the aim of exploiting anopportunity in the food and drink-based wellbeing and functional food sector.The first products of the Group, the Altu food bar range, were launched in themarket in the UK in 2004. The Group's experienced management team are constantlylooking into new ventures to exploit the opportunities in the functional foodsector. The Group successfully floated on AIM in June 2004. This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
31st Jul 20127:00 amRNSFinal Results
27th Jul 20127:00 amRNSNotice of Results
31st May 20127:00 amRNSTotal Voting Rights
17th May 20127:00 amRNSDraw Down of Funds and Issue of Equity
24th Apr 20127:00 amRNSScience in Sport brand relaunch
23rd Apr 20124:31 pmRNSAdditional Listing
2nd Apr 20127:00 amRNSDirectorate Change
30th Mar 201211:46 amRNSTotal Voting Rights Update
30th Mar 20127:00 amRNSPre-Close Update
16th Mar 20124:35 pmRNSPrice Monitoring Extension
12th Mar 20124:40 pmRNSSecond Price Monitoring Extn
12th Mar 20124:35 pmRNSPrice Monitoring Extension
12th Mar 20127:00 amRNSScience in Sport Update
14th Feb 20127:00 amRNSFruitflow update
9th Jan 20124:40 pmRNSSecond Price Monitoring Extn
9th Jan 20124:35 pmRNSPrice Monitoring Extension
9th Jan 20127:00 amRNSProvexis to fuel GB rowing team
7th Dec 20113:01 pmRNSAdditional Listing
1st Dec 20117:00 amRNSChange of adviser
1st Dec 20117:00 amRNSInterim Results
28th Nov 20117:00 amRNSNotice of Interim Results
8th Nov 20117:00 amRNSRenewal of £25 million Equity Financing Facility
24th Aug 20113:24 pmRNSResult of AGM
24th Aug 20117:00 amRNSAGM Statement
8th Aug 20114:40 pmRNSSecond Price Monitoring Extn
8th Aug 20114:35 pmRNSPrice Monitoring Extension
4th Aug 20114:40 pmRNSSecond Price Monitoring Extn
4th Aug 20114:35 pmRNSPrice Monitoring Extension
1st Aug 20115:22 pmRNSNotice of AGM
29th Jul 20117:00 amRNSTotal Voting Rights
26th Jul 20114:46 pmRNSResult of open offer
15th Jul 20114:35 pmRNSHolding(s) in Company
14th Jul 201110:44 amRNSHolding(s) in Company
12th Jul 20114:23 pmRNSHolding(s) in Company
12th Jul 20119:17 amRNSHolding(s) in Company
11th Jul 20111:42 pmRNSChange of Registered Office
5th Jul 20117:00 amRNSOpen Offer
30th Jun 20114:55 pmRNSHolding(s) in Company
30th Jun 20117:00 amRNSTotal Voting Rights
28th Jun 20113:34 pmRNSHolding(s) in Company
24th Jun 201112:08 pmRNSCompletion of the acquisition of SiS
20th Jun 20119:36 amRNSDirector Dealing
17th Jun 20114:15 pmRNSGrant of Options
17th Jun 20117:00 amRNSFinal Results
17th Jun 20117:00 amRNSAcquisition of Science in Sport Ltd
1st Jun 20117:00 amRNSUpdate on Crohn's disease trial
1st Jun 20117:00 amRNSAppointment of New Product Director
1st Jun 20117:00 amRNSSigning of Development Agreement
31st Mar 20117:00 amRNSPre-close update
28th Feb 20118:49 amRNSDevelopment Agreement - Replacement announcement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.